Squamous Non-Small Cell Lung Cancer Therapeutics Market Report

Global and China Squamous Non-Small Cell Lung Cancer Therapeutics Industry Market Research Report (2017-2028)

  • POSTDATE：Oct 28, 2022
  • PAGES：170
  • REPORT CODE：GMM1325681
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Squamous Non-Small Cell Lung Cancer Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • F Hoffmann-La Roche Ltd

    • Bristol-Myers Squibb Company

    • Oncogenex Pharmaceuticals, Inc

    • Eli Lilly and Company

    • MacroGenics, Inc

    • Johnson & Johnson

    • Novartis AG

    • AVEO Pharmaceuticals, Inc

    • PsiOxus Therapeutics Limited

    • Incyte Corporation

    • Genentech, Inc

    • AstraZeneca Plc

    • Bayer AG

    • Boehringer Ingelheim GmbH

    • BIND Therapeutics, Inc

    • Five Prime Therapeutics, Inc

    • Ascenta Therapeutics, Inc

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • BMS-906024

    • Buparlisib Hydrochloride

    • FP-1039

    • Ipilimumab

    • JNJ-42756493

    • Lenvatinib

    • Others

    Application:

    • Research Center

    • Hospital

    • Clinic

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Squamous Non-Small Cell Lung Cancer Therapeutics Industry Overview

      • 1.1.1 Squamous Non-Small Cell Lung Cancer Therapeutics Market Scope and Market Segments

      • 1.1.2 Squamous Non-Small Cell Lung Cancer Therapeutics Industry Characteristics

      • 1.1.3 Global and China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Squamous Non-Small Cell Lung Cancer Therapeutics Production Value and Growth Rate (2017-2028)

    • 1.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 BMS-906024

      • 1.2.2 Buparlisib Hydrochloride

      • 1.2.3 FP-1039

      • 1.2.4 Ipilimumab

      • 1.2.5 JNJ-42756493

      • 1.2.6 Lenvatinib

      • 1.2.7 Others

    • 1.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Research Center

      • 1.3.2 Hospital

      • 1.3.3 Clinic

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Squamous Non-Small Cell Lung Cancer Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Squamous Non-Small Cell Lung Cancer Therapeutics Industry Porter's Five Forces Model Analysis

      • 2.2.3 Squamous Non-Small Cell Lung Cancer Therapeutics Industry PEST Analysis

    • 2.3 Squamous Non-Small Cell Lung Cancer Therapeutics Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Squamous Non-Small Cell Lung Cancer Therapeutics Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Squamous Non-Small Cell Lung Cancer Therapeutics Industry

    Chapter 3 Global and China Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Manufacturer

    • 3.1 Global and China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Squamous Non-Small Cell Lung Cancer Therapeutics Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Squamous Non-Small Cell Lung Cancer Therapeutics Market Top 3 Players

    Chapter 4 Global and China Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Type (2017-2028)

    • 4.1 Squamous Non-Small Cell Lung Cancer Therapeutics Market Trend, by Type

    • 4.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Price Trend, by Type (2017-2028)

    • 4.3 China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Squamous Non-Small Cell Lung Cancer Therapeutics Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Squamous Non-Small Cell Lung Cancer Therapeutics Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Squamous Non-Small Cell Lung Cancer Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Squamous Non-Small Cell Lung Cancer Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Squamous Non-Small Cell Lung Cancer Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis

    • 7.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Type

    • 7.2 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Application

    • 7.3 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis and Forecast, by Country

      • 7.3.1 United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis

    • 8.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Type

    • 8.2 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Application

    • 8.3 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis and Forecast, by Country

      • 8.3.1 Germany Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis

    • 9.1 APAC Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Type

    • 9.2 APAC Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Application

    • 9.3 APAC Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis and Forecast, by Country

      • 9.3.1 China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis

    • 10.1 Latin America, Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Type

    • 10.2 Latin America, Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market, by Application

    • 10.3 Latin America, Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Squamous Non-Small Cell Lung Cancer Therapeutics Company Profiles

      • 11.1 F Hoffmann-La Roche Ltd

        • 11.1.1 F Hoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 F Hoffmann-La Roche Ltd Squamous Non-Small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.1.3 F Hoffmann-La Roche Ltd Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Bristol-Myers Squibb Company

        • 11.2.1 Bristol-Myers Squibb Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.2.3 Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Oncogenex Pharmaceuticals, Inc

        • 11.3.1 Oncogenex Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Oncogenex Pharmaceuticals, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.3.3 Oncogenex Pharmaceuticals, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Eli Lilly and Company

        • 11.4.1 Eli Lilly and Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.4.3 Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 MacroGenics, Inc

        • 11.5.1 MacroGenics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 MacroGenics, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.5.3 MacroGenics, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Johnson & Johnson

        • 11.6.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.6.3 Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Novartis AG

        • 11.7.1 Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.7.3 Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 AVEO Pharmaceuticals, Inc

        • 11.8.1 AVEO Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 AVEO Pharmaceuticals, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.8.3 AVEO Pharmaceuticals, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 PsiOxus Therapeutics Limited

        • 11.9.1 PsiOxus Therapeutics Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.9.3 PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Incyte Corporation

        • 11.10.1 Incyte Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.10.3 Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Genentech, Inc

        • 11.11.1 Genentech, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Genentech, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.11.3 Genentech, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 AstraZeneca Plc

        • 11.12.1 AstraZeneca Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.12.3 AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Bayer AG

        • 11.13.1 Bayer AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.13.3 Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Boehringer Ingelheim GmbH

        • 11.14.1 Boehringer Ingelheim GmbH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.14.3 Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 BIND Therapeutics, Inc

        • 11.15.1 BIND Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 BIND Therapeutics, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.15.3 BIND Therapeutics, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Five Prime Therapeutics, Inc

        • 11.16.1 Five Prime Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Five Prime Therapeutics, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.16.3 Five Prime Therapeutics, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 Ascenta Therapeutics, Inc

        • 11.17.1 Ascenta Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 Ascenta Therapeutics, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Product Profiles, Application and Specification

        • 11.17.3 Ascenta Therapeutics, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Squamous Non-Small Cell Lung Cancer Therapeutics Industry Investment Prospect and Risk Assessment

    • 12.1 Squamous Non-Small Cell Lung Cancer Therapeutics Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Squamous Non-Small Cell Lung Cancer Therapeutics Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate of BMS-906024 (2017-2028)

    • Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Buparlisib Hydrochloride (2017-2028)

    • Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate of FP-1039 (2017-2028)

    • Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Ipilimumab (2017-2028)

    • Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate of JNJ-42756493 (2017-2028)

    • Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Lenvatinib (2017-2028)

    • Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Research Center (2017-2028)

    • Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size and Growth Rate of Clinic (2017-2028)

    • Figure North America Squamous Non-Small Cell Lung Cancer Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Squamous Non-Small Cell Lung Cancer Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Squamous Non-Small Cell Lung Cancer Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Squamous Non-Small Cell Lung Cancer Therapeutics Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Squamous Non-Small Cell Lung Cancer Therapeutics Market Share, by Manufacturer in 2021

    • Figure Global and China Squamous Non-Small Cell Lung Cancer Therapeutics Market Share, by Manufacturer in 2022

    • Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, by Type (2017-2028)

    • Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value, by Type (2017-2028)

    • Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Price Trend, by Type (2017-2028)

    • Table China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, by Type (2017-2028)

    • Table China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value, by Type (2017-2028)

    • Table China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Price Trend, by Type (2017-2028)

    • Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, by Application (2017-2028)

    • Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value, by Application (2017-2028)

    • Table Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure Global Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value Share, by Application (2017-2028)

    • Table China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, by Application (2017-2028)

    • Table China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value, by Application (2017-2028)

    • Table China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure North America Squamous Non-Small Cell Lung Cancer Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Squamous Non-Small Cell Lung Cancer Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Squamous Non-Small Cell Lung Cancer Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Table North America Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, by Type (2017-2028)

    • Table North America Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure North America Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table North America Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, by Application (2017-2028)

    • Table North America Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure North America Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure United States Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Canada Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, by Type (2017-2028)

    • Table Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, by Application (2017-2028)

    • Table Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Europe Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Germany Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure UK Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure UK Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure France Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure France Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Italy Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Spain Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Poland Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Russia Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table APAC Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, by Type (2017-2028)

    • Table APAC Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure APAC Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table APAC Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, by Application (2017-2028)

    • Table APAC Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure APAC Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Japan Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure India Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure India Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Squamous Non-Small Cell Lung Cancer Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table F Hoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table F Hoffmann-La Roche Ltd Product Profiles, Application and Specification

    • Table F Hoffmann-La Roche Ltd Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bristol-Myers Squibb Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bristol-Myers Squibb Company Product Profiles, Application and Specification

    • Table Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Oncogenex Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Oncogenex Pharmaceuticals, Inc Product Profiles, Application and Specification

    • Table Oncogenex Pharmaceuticals, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly and Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly and Company Product Profiles, Application and Specification

    • Table Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table MacroGenics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table MacroGenics, Inc Product Profiles, Application and Specification

    • Table MacroGenics, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis AG Product Profiles, Application and Specification

    • Table Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AVEO Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AVEO Pharmaceuticals, Inc Product Profiles, Application and Specification

    • Table AVEO Pharmaceuticals, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table PsiOxus Therapeutics Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table PsiOxus Therapeutics Limited Product Profiles, Application and Specification

    • Table PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Incyte Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Incyte Corporation Product Profiles, Application and Specification

    • Table Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Genentech, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Genentech, Inc Product Profiles, Application and Specification

    • Table Genentech, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca Plc Product Profiles, Application and Specification

    • Table AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bayer AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer AG Product Profiles, Application and Specification

    • Table Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Boehringer Ingelheim GmbH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Boehringer Ingelheim GmbH Product Profiles, Application and Specification

    • Table Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table BIND Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table BIND Therapeutics, Inc Product Profiles, Application and Specification

    • Table BIND Therapeutics, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Five Prime Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Five Prime Therapeutics, Inc Product Profiles, Application and Specification

    • Table Five Prime Therapeutics, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ascenta Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ascenta Therapeutics, Inc Product Profiles, Application and Specification

    • Table Ascenta Therapeutics, Inc Squamous Non-Small Cell Lung Cancer Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US